Acute bleeding complications in patients after bone marrow transplantation

Research output: Contribution to journalArticle

Abstract

Acute bleeding is a frequent complication that commonly associates with increased morbidity after bone marrow transplantation. Except for diffuse alveolar hemorrhage and cerebral hemorrhage, bleeding is infrequently recorded as a direct cause of death. Yet outcome analyses showed that bleeding from any reviewed site was associated with reduced survival. Reduced survival was correlated with bleeding intensity and the number of bleeding sites. These data point to the need to monitor all manifestations of bleeding, as bleeding may identify patients at risk for bone marrow transplantation toxicity. Until recently, prophylactic platelet transfusions were commonly given at a trigger of 20 × 109/L. Whereas bleeding is more likely to occur when platelet counts drop to low levels, most bleeding episodes were recorded with platelet counts greater than 20 × 109/L, suggesting causes other than profound thrombocytopenia in the pathogenesis of bleeding. Given that a trigger of 10 × 109/L has become accepted for prophylactic platelet transfusions, care should be taken to ensure that parameters other than the incidence of bleeding have not been adversely affected.

Original languageEnglish (US)
Pages (from-to)319-325
Number of pages7
JournalCurrent Opinion in Hematology
Volume8
Issue number5
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Bone Marrow Transplantation
Hemorrhage
Platelet Transfusion
Platelet Count
Survival
Cerebral Hemorrhage
Thrombocytopenia
Cause of Death
Morbidity

ASJC Scopus subject areas

  • Hematology

Cite this

Acute bleeding complications in patients after bone marrow transplantation. / Nevo, Shoshan; Vogelsang, Georgia Boyce.

In: Current Opinion in Hematology, Vol. 8, No. 5, 2001, p. 319-325.

Research output: Contribution to journalArticle

@article{446cdfc66d3445149eccc8f3e8c2334c,
title = "Acute bleeding complications in patients after bone marrow transplantation",
abstract = "Acute bleeding is a frequent complication that commonly associates with increased morbidity after bone marrow transplantation. Except for diffuse alveolar hemorrhage and cerebral hemorrhage, bleeding is infrequently recorded as a direct cause of death. Yet outcome analyses showed that bleeding from any reviewed site was associated with reduced survival. Reduced survival was correlated with bleeding intensity and the number of bleeding sites. These data point to the need to monitor all manifestations of bleeding, as bleeding may identify patients at risk for bone marrow transplantation toxicity. Until recently, prophylactic platelet transfusions were commonly given at a trigger of 20 × 109/L. Whereas bleeding is more likely to occur when platelet counts drop to low levels, most bleeding episodes were recorded with platelet counts greater than 20 × 109/L, suggesting causes other than profound thrombocytopenia in the pathogenesis of bleeding. Given that a trigger of 10 × 109/L has become accepted for prophylactic platelet transfusions, care should be taken to ensure that parameters other than the incidence of bleeding have not been adversely affected.",
author = "Shoshan Nevo and Vogelsang, {Georgia Boyce}",
year = "2001",
doi = "10.1097/00062752-200109000-00009",
language = "English (US)",
volume = "8",
pages = "319--325",
journal = "Current Opinion in Hematology",
issn = "1065-6251",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Acute bleeding complications in patients after bone marrow transplantation

AU - Nevo, Shoshan

AU - Vogelsang, Georgia Boyce

PY - 2001

Y1 - 2001

N2 - Acute bleeding is a frequent complication that commonly associates with increased morbidity after bone marrow transplantation. Except for diffuse alveolar hemorrhage and cerebral hemorrhage, bleeding is infrequently recorded as a direct cause of death. Yet outcome analyses showed that bleeding from any reviewed site was associated with reduced survival. Reduced survival was correlated with bleeding intensity and the number of bleeding sites. These data point to the need to monitor all manifestations of bleeding, as bleeding may identify patients at risk for bone marrow transplantation toxicity. Until recently, prophylactic platelet transfusions were commonly given at a trigger of 20 × 109/L. Whereas bleeding is more likely to occur when platelet counts drop to low levels, most bleeding episodes were recorded with platelet counts greater than 20 × 109/L, suggesting causes other than profound thrombocytopenia in the pathogenesis of bleeding. Given that a trigger of 10 × 109/L has become accepted for prophylactic platelet transfusions, care should be taken to ensure that parameters other than the incidence of bleeding have not been adversely affected.

AB - Acute bleeding is a frequent complication that commonly associates with increased morbidity after bone marrow transplantation. Except for diffuse alveolar hemorrhage and cerebral hemorrhage, bleeding is infrequently recorded as a direct cause of death. Yet outcome analyses showed that bleeding from any reviewed site was associated with reduced survival. Reduced survival was correlated with bleeding intensity and the number of bleeding sites. These data point to the need to monitor all manifestations of bleeding, as bleeding may identify patients at risk for bone marrow transplantation toxicity. Until recently, prophylactic platelet transfusions were commonly given at a trigger of 20 × 109/L. Whereas bleeding is more likely to occur when platelet counts drop to low levels, most bleeding episodes were recorded with platelet counts greater than 20 × 109/L, suggesting causes other than profound thrombocytopenia in the pathogenesis of bleeding. Given that a trigger of 10 × 109/L has become accepted for prophylactic platelet transfusions, care should be taken to ensure that parameters other than the incidence of bleeding have not been adversely affected.

UR - http://www.scopus.com/inward/record.url?scp=0034837103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034837103&partnerID=8YFLogxK

U2 - 10.1097/00062752-200109000-00009

DO - 10.1097/00062752-200109000-00009

M3 - Article

C2 - 11604568

AN - SCOPUS:0034837103

VL - 8

SP - 319

EP - 325

JO - Current Opinion in Hematology

JF - Current Opinion in Hematology

SN - 1065-6251

IS - 5

ER -